US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 5.530
  • +0.150+2.79%
Close Oct 16 16:00 ET
  • 5.620
  • +0.090+1.63%
Post 20:02 ET
238.60MMarket Cap-2603P/E (TTM)

About Kyverna Therapeutics Company

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Company Profile

SymbolKYTX
Company NameKyverna Therapeutics
Listing DateFeb 8, 2024
Issue Price22.00
CEOMr. Warner Biddle
MarketNASDAQ
Employees96
Fiscal Year Ends12-31
Address5980 Horton Street,Suite 550
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-925-2492
Websitehttp://www.kyvernatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Warner Biddle
  • Chief Executive Officer and Director
  • --
  • Ryan Jones
  • Chief Financial Officer
  • --
  • James Chung, M.D.
  • Chief Medical Officer
  • 1.17M
  • Karen Walker
  • Chief Technology Officer
  • 1.08M
  • Dominic Borie, M.D.
  • President, Research and Development
  • --
  • Ian T. Clark
  • Chairman of the Board
  • 306.74K
  • Christi Shaw
  • Director
  • --
  • Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
  • Independent Director
  • 155.05K
  • Dr. Beth C. Seidenberg,M.D.
  • Independent Director
  • 155.05K
  • Daniel K. Spiegelman
  • Independent Director
  • 245.05K
  • Dr. Steve Liapis, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data